Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease
Kidney Int Rep
.
2023 Feb 17;8(5):1102-1104.
doi: 10.1016/j.ekir.2023.02.1070.
eCollection 2023 May.
Authors
Nan Guan
1
,
Min Zhang
1
,
Min Zhang
1
,
Ruiying Chen
1
,
Qionghong Xie
1
,
Chuan-Ming Hao
1
Affiliation
1
Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
PMID:
37180513
PMCID:
PMC10166732
DOI:
10.1016/j.ekir.2023.02.1070
No abstract available
Keywords:
initial therapy; minimal change disease; nephrotic syndrome; rituximab.